FNA - Paragon 28, Inc.
Close
9.975
-0.045 -0.451%
Share volume: 2,361
Last Updated: Fri 27 Dec 2024 06:30:21 PM CET
Surgical and Medical Instrument Manufacturing :
-0.07%
PREVIOUS CLOSE
CHG
CHG%
$10.02
-0.05
-0.45%
Fundamental analysis
9%
Profitability
0%
Dept financing
19%
Liquidity
34%
Performance
10%
Performance
5 Days
1.78%
1 Month
2.91%
3 Months
59.47%
6 Months
63.54%
1 Year
-21.78%
2 Year
-51.35%
Key data
Stock price
$9.98
DAY RANGE
$9.96 - $10.37
52 WEEK RANGE
$5.02 - $14.79
52 WEEK CHANGE
-$18.75
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/05/2024
Company detail
CEO: Albert DaCosta
Region: US
Website: paragon28.com
Employees: 343,000
IPO year: -
Issue type: Common Stock
Market: NYSE
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing
Region: US
Website: paragon28.com
Employees: 343,000
IPO year: -
Issue type: Common Stock
Market: NYSE
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing
Paragon 28, Inc. designs, develops, distributes, and sells foot and ankle surgical systems. It offers gorilla plating systems, including gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates. The company also provides precision guide technology for various procedures consisting of fusion, a procedure to address bunion deformities.
Recent news